CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies

NCT04156178 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

iCell Gene Therapeutics

Collaborators